7LBA Safety, activity, and response durability assessment of single agent rovalpituzumab tesirine, a delta-like protein 3 (DLL3)-targeted antibody drug conjugate (ADC), in small cell lung cancer (SCLC)

2015 ◽  
Vol 51 ◽  
pp. S712 ◽  
Author(s):  
M.C. Pietanza ◽  
D. Spigel ◽  
T.M. Bauer ◽  
N.E. Ready ◽  
B.S. Glisson ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Single Agent ◽  
Small Cell ◽  
Small Cell Lung ◽  
Antibody Drug Conjugate ◽  
Drug Conjugate ◽  
Durability Assessment ◽  
Antibody Drug

scholarly journals A GPC2 antibody-drug conjugate is efficacious against neuroblastoma and small-cell lung cancer via binding a conformational epitope

2021 ◽  
Vol 2 (7) ◽  
pp. 100344
Author(s):  
Swetha Raman ◽  
Samantha N. Buongervino ◽  
Maria V. Lane ◽  
Doncho V. Zhelev ◽  
Zhongyu Zhu ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Conformational Epitope ◽  
Small Cell ◽  
Small Cell Lung ◽  
Antibody Drug Conjugate ◽  
Drug Conjugate ◽  
Antibody Drug
Sign in / Sign up

Export Citation Format

Share Document